Ardena continues M&A strategy with CMO buy
CDMO Ardena has added drug product capabilities with the purchase of active pharmaceutical ingredient and excipient-focused Syntagon.
CDMO Ardena has added drug product capabilities with the purchase of active pharmaceutical ingredient and excipient-focused Syntagon.
PolarityTE has acquired a preclinical biomedical research facility which will serve as a CRO to accelerate research and development and “help drive the field of biotechnology,” says CEO.
Inadequate temperature control and a lack of ‘appropriately’ designed manufacturing equipment are among the GMP violations that landed Goran Pharma a warning letter.
NEWS IN BRIEF
A predicted increase of complex molecule production and last-minute packaging requirements is behind Tjoapack’s latest investment in the Netherlands.
UPDATE
Icon has announced a clinical research partnership with DuPage Medical Group, a Chicago, IL-based network with more than 700 physicians across more than 100 locations.
The US FDA has issued a policy that provides the proper definition of an outsourcing facility in an effort to ensure compounded drugs are made under appropriate quality standards.